体重指数对生物药物对严重喘的影响
Styliani Papadopoulou1, Christodoulos Komiotis1, Fotios Drakopanagiotakis2
1Medical School, Faculty of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
Pulmonary therapy
|March 11, 2026
概括
生物药物在肥胖的严重喘患者中表现出不同的有效性. 梅波利祖马布,本拉利祖马布和复利祖马布在较高的BMI群体中似乎效果较差,而dupilumab在BMI水平上保持一致.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘与更高的体重指数 (BMI) 相关,增加患病率和发病率.
- 生物药物为严重喘提供了新的治疗途径.
- 有限的研究存在于严重喘的肥胖患者的生物药物的疗效.
研究的目的:
- 系统地审查身体质量指数 (BMI) 与治疗治疗严重喘的五种新生物药物的反应之间的关联.
主要方法:
- 按照PRISMA指南进行系统审查.
- 在PubMed/Medline和Scopus数据库进行文献搜索,截至2025年5月.
- 包括关于梅波利祖马布,本拉利祖马布,杜比卢马布,雷斯利祖马布和特泽佩卢马布的研究,选择了21篇文章.
主要成果:
- 梅波利祖马布的缓解率较低,BMI较高;BMI<30 kg/m2与更好的结果相关.
- 本拉利祖马布在BMI ≤35 kg/m2时显示有效,但BMI >35 kg/m2时没有.
- 杜皮卢马布在所有BMI水平上都有效;随着BMI的提高,reslizumab的有效性下降;没有对tezepelumab的数据.
结论:
- 梅波利祖马布,本拉利祖马布和复利祖马布在具有较高BMI的严重喘患者中可能效果较差.
- 杜皮卢马布无论BMI如何都显示出一致的疗效.
- 需要对肥胖人口中严重喘的生物疗法进行进一步的研究.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
342
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342
01:21Drug Dosing: Obese Patients
325
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K